Characterization of two new high-grade B-cell lymphoma cell lines with MYC and BCL2 rearrangements that are suitable for in vitro drug sensitivity studies

被引:1
作者
Dheur, Marie-Sophie [1 ]
Poirel, Helene A. [2 ]
Ameye, Genevieve [2 ]
Tilman, Gaelle [2 ]
Saussoy, Pascale [3 ]
Defour, Jean-Philippe [3 ]
Camboni, Alessandra [4 ,5 ]
Van den Neste, Eric [5 ]
Coulie, Pierre G. [1 ]
van Baren, Nicolas [1 ]
机构
[1] Catholic Univ Louvain, Duve Inst, Cellular Genet Unit, Ave Hippocrate 75-B1-74-04, B-1200 Brussels, Belgium
[2] Catholic Univ Louvain, Clin Univ St Luc, Ctr Genet Humaine, Brussels, Belgium
[3] Catholic Univ Louvain, Clin Univ St Luc, Dept Clin Biol, Brussels, Belgium
[4] Catholic Univ Louvain, Clin Univ St Luc, Dept Pathol, Brussels, Belgium
[5] Catholic Univ Louvain, Clin Univ St Luc, Dept Hematol, Brussels, Belgium
关键词
High-grade double-hit lymphoma; cell lines; MYC; BCL2; RITUXIMAB PLUS CYCLOPHOSPHAMIDE; FOLLICULAR LYMPHOMA; MUTATIONS; VINCRISTINE; DOXORUBICIN; EXPRESSION; INHIBITOR; PROTEINS; ABT-199;
D O I
10.1080/10428194.2018.1508663
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
High-grade B-cell lymphomas with MYC and BCL2 or BCL6 rearrangements are highly aggressive B-cell lymphomas called double-hit lymphomas (HGBL-DH). They are particularly refractory to standard treatments and carry a poor prognosis. Fragments of resected tumoral lymph nodes from two HGBL-DH patients were put in culture. Continuously proliferating cells were characterized and compared with the original tumors. In both cases, the proliferating cells and the tumor displayed MYC and BCL2 rearrangements. Both cell lines (called LB5848-LYMP and LB5871-LYMP) presented a high proliferation rate and were maintained in culture for more than one year. Upon injection in immunodeficient mice, LB5848-LYMP gave rise to lymphoid tumors. In vitro treatment of these cell lines with a BCL2-inhibitory drug (ABT-199) selectively stopped their proliferation. These new cell lines represent valuable tools for studying HGBL-DH and for the in vitro testing of candidate therapies targeting HGBL-DH. LB5848-LYMP is also suitable for similar experiments in vivo.
引用
收藏
页码:1043 / 1052
页数:10
相关论文
共 30 条
[1]   Current challenges and novel treatment strategies in double hit lymphomas [J].
Anderson, Mary Ann ;
Tsui, Alpha ;
Wall, Meaghan ;
Huang, David C. S. ;
Roberts, Andrew W. .
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (01) :52-64
[2]  
[Anonymous], 2017, WHO CLASSIFICATION T
[3]   Roles of BCL6 in normal and transformed germinal center B cells [J].
Basso, Katia ;
Dalla-Favera, Riccardo .
IMMUNOLOGICAL REVIEWS, 2012, 247 :172-183
[4]   Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets [J].
Bouska, Alyssa ;
Bi, Chengfeng ;
Lone, Waseem ;
Zhang, Weiwei ;
Kedwaii, Ambreen ;
Heavican, Tayla ;
Lachel, Cynthia M. ;
Yu, Jiayu ;
Ferro, Roberto ;
Eldorghamy, Nanees ;
Greiner, Timothy C. ;
Vose, Julie ;
Weisenburger, Dennis D. ;
Gascoyne, Randy D. ;
Rosenwald, Andreas ;
Ott, German ;
Campo, Elias ;
Rimsza, Lisa M. ;
Jaffe, Elaine S. ;
Braziel, Rita M. ;
Siebert, Reiner ;
Miles, Rodney R. ;
Dave, Sandeep ;
Reddy, Anupama ;
Delabie, Jan ;
Staudt, Louis M. ;
Song, Joo Y. ;
McKeithan, Timothy W. ;
Fu, Kai ;
Green, Michael ;
Chan, Wing C. ;
Iqbal, Javeed .
BLOOD, 2017, 130 (16) :1819-1831
[5]   Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse Prognosis [J].
Cheung, K-John J. ;
Johnson, Nathalie A. ;
Affleck, Joslynn G. ;
Severson, Tesa ;
Steidl, Christian ;
Ben-Neriah, Susana ;
Schein, Jacqueline ;
Morin, Ryan D. ;
Moore, Richard ;
Shah, Sohrab P. ;
Qian, Hong ;
Paul, Jessica E. ;
Telenius, Adele ;
Relander, Thomas ;
Lam, Wan ;
Savage, Kerry ;
Connors, Joseph M. ;
Brown, Carolyn ;
Marra, Marco A. ;
Gascoyne, Randy D. ;
Horsman, Douglas E. .
CANCER RESEARCH, 2010, 70 (22) :9166-9174
[6]   Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy [J].
Czabotar, Peter E. ;
Lessene, Guillaume ;
Strasser, Andreas ;
Adams, Jerry M. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2014, 15 (01) :49-63
[7]   The c-Myc target gene network [J].
Dang, Chi V. ;
O'Donnell, Kathryn A. ;
Zeller, Karen I. ;
Nguyen, Tam ;
Osthus, Rebecca C. ;
Li, Feng .
SEMINARS IN CANCER BIOLOGY, 2006, 16 (04) :253-264
[8]   Malignant hematopoietic cell lines: in vitro models for double-hit B-cell lymphomas [J].
Drexler, Hans G. ;
Eberth, Sonja ;
Nagel, Stefan ;
MacLeod, Roderick A. F. .
LEUKEMIA & LYMPHOMA, 2016, 57 (05) :1015-1020
[9]   Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study [J].
Dubois, Sydney ;
Viailly, Pierre-Julien ;
Mareschal, Sylvain ;
Bohers, Elodie ;
Bertrand, Philippe ;
Ruminy, Philippe ;
Maingonnat, Catherine ;
Jais, Jean-Philippe ;
Peyrouze, Pauline ;
Figeac, Martin ;
Molina, Thierry J. ;
Desmots, Fabienne ;
Fest, Thierry ;
Haioun, Corinne ;
Lamy, Thierry ;
Copie-Bergman, Christiane ;
Briere, Josette ;
Petrella, Tony ;
Canioni, Danielle ;
Fabiani, Bettina ;
Coiffier, Bertrand ;
Delarue, Richard ;
Peyrade, Frederic ;
Bosly, Andre ;
Andre, Marc ;
Ketterer, Nicolas ;
Salles, Gilles ;
Tilly, Herve ;
Leroy, Karen ;
Jardin, Fabrice .
CLINICAL CANCER RESEARCH, 2016, 22 (12) :2919-2928
[10]   Refinement of 1p36 Alterations Not Involving PRDM16 in Myeloid and Lymphoid Malignancies [J].
Duhoux, Francois P. ;
Ameye, Genevieve ;
Lambot, Virginie ;
Herens, Christian ;
Lambert, Frederic ;
Raynaud, Sophie ;
Wlodarska, Iwona ;
Michaux, Lucienne ;
Roche-Lestienne, Catherine ;
Labis, Elise ;
Taviaux, Sylvie ;
Chapiro, Elise ;
Florence Nguyen Khac ;
Struski, Stephanie ;
Dobbelstein, Sophie ;
Dastugue, Nicole ;
Lippert, Eric ;
Speleman, Frank ;
Van Roy, Nadine ;
De Weer, An ;
Rack, Katrina ;
Talmant, Pascaline ;
Richebourg, Steven ;
Mugneret, Francine ;
Tigaud, Isabelle ;
Mozziconacci, Marie-Joelle ;
Laibe, Sophy ;
Nadal, Nathalie ;
Terre, Christine ;
Libouton, Jeanne-Marie ;
Decottignies, Anabelle ;
Vikkula, Miikka ;
Poirel, Helene A. .
PLOS ONE, 2011, 6 (10)